Prognostic impact of recurrence pattern for surgically resected non-small cell lung cancer [0.03%]
复发模式对术后非小细胞肺癌患者预后的影响
Nozomu Motono,Takaki Mizoguchi,Masahito Ishikawa et al.
Nozomu Motono et al.
Introduction: Although several prognostic risk factors have been identified for non-small cell lung cancer (NSCLC) patients who undergo pulmonary resection, the significance of several factors remains unclear, including t...
Patient-reported outcome-based symptom management improves QoL in postoperative gastroesophageal cancer patients: A Randomized Controlled Trial [0.03%]
基于患者报告结果的症状管理可改善食管胃交界部癌术后患者的生存质量：一项随机对照试验
Shusheng Wu,Jiayu Niu,Conglan Ding et al.
Shusheng Wu et al.
Objective: Following resection for gastroesophageal cancer, patients may experience symptoms like reflux, anorexia, and weight loss that can significantly impact their quality of life (QoL). Patient-reported outcomes (PRO...
Factors relating to Tumor size and survival in patients with hepatocellular carcinoma: significance of PLR, PVT and albumin [0.03%]
与肝细胞癌肿瘤大小和生存相关因素的研究：PLR、门静脉侵犯及白蛋白的作用意义
Rossella Donghia,Brian Irving Carr,Sezai Yilmaz
Rossella Donghia
Background and objectives: Maximum tumor diameter (MTD) is one of the key aggressiveness features of hepatocellular carcinoma (HCC). However, the clinical associations and causes of large size HCC are not well understood....
Mechanism research and application prospect of non-coding RNA regulating tumor cell pyroptosis [0.03%]
非编码RNA调控肿瘤细胞焦亡的机制研究及应用前景
Wang Wan,QiYang Mao,ZhuoHong Ye et al.
Wang Wan et al.
Background: Noncoding RNAs (ncRNAs), including microRNAs, lncRNAs, and circRNAs, play essential roles in physiological and pathological processes, including cancer, where they act as drivers or suppressors. Aberrant ncRNA...
Anti-Histamines Improve the Survival of Lung Cancer: a 10-year Cohort Study of Tertiary Hospital in Taiwan [0.03%]
抗组胺药改善肺癌患者的生存率：一项来自台湾地区三级医院的十年队列研究
Chun-Hsiang Hsu,Chiu-Fan Chen,Chun-Hao Yin et al.
Chun-Hsiang Hsu et al.
Introduction: Antihistamines (AHs) have beneficial effects as adjuvant anti-cancer agent in several preclinical and observational studies. We aim to evaluate the effect of AHs on stage IV lung cancer patients. ...
Jia Yi Tan,Boon Jian San,Tze Ern Ong et al.
Jia Yi Tan et al.
Introduction The incidence of multiple myeloma (MM) in the United States has been increasing over the past decades with persistent demographic disparities. Social determinants of health (SDOH) were found to affect health outcomes among cert...
The Effectiveness of Long-Term Continuation of Atezolizumab plus Bevacizumab in Patients Receiving Systemic Chemotherapy for Advanced Hepatocellular Carcinoma: A Multicenter Study [0.03%]
长期继续使用阿特珠单抗联合贝伐珠单抗对接受系统化疗的晚期肝细胞癌患者的疗效：一项多中心研究
Takanori Suzuki,Kiyoto Narita,Kentaro Matsuura et al.
Takanori Suzuki et al.
Introduction: Changes in liver function in patients with unresectable hepatocellular carcinoma (u-HCC), following extended periods from the initiation of atezolizumab plus bevacizumab (Atez/Bev), have not been fully inves...
Cachexia Index as a Prognostic Indicator in Patients with Unresectable Hepatocellular Carcinoma Receiving Atezolizumab and Bevacizumab Therapy [0.03%]
缓症指数作为不可切除肝细胞癌接受阿特珠单抗和贝伐珠单抗治疗患者的预后指标
Khanh Van Nguyen,Kosuke Matsui,Hisashi Kosaka et al.
Khanh Van Nguyen et al.
Background and aim: We investigated the association between the pretreatment cachexia index (CXI) and survival outcomes in patients with unresectable hepatocellular carcinoma (u-HCC) receiving atezolizumab plus bevacizuma...
Changes in tumor-infiltrating lymphocytes and inflammatory blood factors during CRT in rectal cancer [0.03%]
直肠癌患者放化疗期间肿瘤浸润淋巴细胞及炎症血液因子的变化
Hiroshi Miyakita,Takashi Ogimi,Hajime Kayano et al.
Hiroshi Miyakita et al.
Introduction: Multidisciplinary treatments for advanced rectal cancer are diverse. Neoadjuvant chemoradiation therapy (nCRT) is a total neoadjuvant therapy treatment option. Some studies have reported that tumor-infiltrat...
Modified Glasgow prognostic score as a marker for predicting outcomes in patients with either bladder and prostate cancer : A systematic review and meta-analysis [0.03%]
改良版格拉斯哥预后评分作为预测膀胱癌和前列腺癌患者结局的指标: 系统综述和荟萃分析
Jie Chen,Suna Fu,Jianhong Yu et al.
Jie Chen et al.
Objective: To investigate the association of pretreatment-modified Glasgow Prognostic Score (mGPS) with survival-related outcomes in patients with bladder cancer (BC) and prostate cancer (PC). ...